U.S. Hospitality Stock News

If you are wondering whether PulteGroup's current share price still offers value, you are not alone. The stock has attracted a lot of attention from investors checking if the homebuilder is priced fairly. PulteGroup's share price last closed at US$125.09, with returns of negative 0.1% over 7 days, 6.7% over 30 days, 5.1% year to date, 10.8% over 1 year and a very large gain over 3 and 5 years. Recent coverage has focused on PulteGroup within the US homebuilding sector, as investors track how...

Hanover Bancorp (HNVR) has laid out its FY 2025 scorecard with fiscal third quarter revenue of US$16.7 million and EPS of US$0.47, alongside trailing twelve month revenue of US$68.0 million and EPS of US$1.52, giving investors a clear read on recent earnings power. Over the past year, the company has seen revenue move from US$59.8 million to US$68.0 million on a trailing basis, while trailing EPS shifted from US$1.66 to US$1.52. This sets the backdrop for a conversation about how its 16.2%...

Ecolab (NYSE:ECL) is reporting strong momentum in its Digital and Global High-Tech segments. These technology focused businesses are expanding even as the company faces tariff related inflation and softer demand in some areas. The mix of growth in high tech offerings and external cost pressures is a key theme for investors tracking Ecolab's next phase. Ecolab, trading at $281.99, is putting more weight behind its digital and high tech solutions at a time when parts of its portfolio are...

MetroCity Bankshares (MCBS) has reported Q3 FY 2025 results with total revenue of US$38.5 million and basic EPS of US$0.68, alongside net income of US$17.3 million, giving investors a fresh read on the bank’s earnings power. The company has seen trailing twelve month revenue shift from US$126.4 million in Q2 2024 to US$147.3 million in Q3 2025, with EPS over that same trailing window moving from US$2.15 to US$2.62. This sets up a results season where margins and earnings quality are front of...

Utah Medical Products (UTMD) closed FY 2025 with Q4 revenue of US$9.0 million and basic EPS of US$0.80, setting the tone for a year where earnings and sales moved within a relatively tight range. Over the past six quarters, quarterly revenue has run between US$9.0 million and US$10.0 million while basic EPS has ranged from about US$0.80 to US$1.02. This gives investors a clear look at how top line and EPS have tracked together through FY 2024 into FY 2025. With trailing net margins easing and...

ANI Pharmaceuticals recently reported revenue growth of 53.60% and continues to broaden its product portfolio and distribution channels, drawing strong interest from analysts and investors alike. With seven buy ratings and widespread optimism about its expanding business footprint, the company’s position within the pharmaceutical sector is gaining increased attention. Next, we’ll examine how ANI Pharmaceuticals’ rapid revenue growth shapes its investment narrative and what it could mean for...

Rhinebeck Bancorp (RBKB) has just posted its FY 2025 numbers, with fourth quarter revenue of US$13.0 million and EPS of US$0.22, while over the trailing twelve months revenue came in at US$51.7 million and EPS reached US$0.93. The company has seen revenue move from US$25.9 million and an EPS loss of US$0.80 over the trailing year to Q4 2024 to US$51.7 million and EPS of US$0.93 over the latest trailing period, giving investors a clear set of revenue and EPS figures to weigh. With a net...

Flagstar Bank National Association (FLG) has just posted another loss for Q3 2025, reporting total revenue of US$481 million and a net loss of US$45 million, or EPS of US$0.11. This keeps the full year firmly in loss making territory so far. Over recent periods the bank has seen revenue move from US$281 million in Q2 2024 to US$381 million in Q3 2024, then to US$480 million in Q4 2024, and US$411 million, US$432 million and US$481 million across Q1 to Q3 2025. Quarterly EPS has ranged between...

How Eastman Chemical's FY 2025 Numbers Set Up the Next Part of the Story Eastman Chemical (EMN) has wrapped up FY 2025 with fourth quarter revenue of US$1,973 million, Basic EPS of US$0.92 and net income excluding extraordinary items of US$105 million. The trailing twelve months show revenue of US$8.75 billion, Basic EPS of US$4.13 and net income of US$474 million. Over the past few quarters, the company has reported revenue moving from US$2,464 million in Q3 2024 to US$1,973 million in Q4...

If you are wondering whether Ralliant's current share price gives you good value for your money, you are not alone. This article is built to help you assess that. Over the short term, the stock has seen a 1.4% decline over the past week, a 4.0% gain over the last 30 days and a 3.4% return year to date, which has likely caught the attention of investors tracking short term moves. Recent coverage has focused on Ralliant's position in the tech sector and how investors are reacting to its latest...

Church & Dwight (CHD) just posted its FY 2025 third quarter numbers, with revenue of US$1,585.6 million and basic EPS of US$0.75, alongside net income of US$182.2 million. The company has seen quarterly revenue move from US$1,511.2 million in Q2 2024 to US$1,582.0 million in Q4 2024 and then to US$1,585.6 million in Q3 2025. Over the same periods, basic EPS shifted from US$1.00 to US$0.77 and then to US$0.75, creating a picture in which the headline growth story is now as much about how...

On 29 January 2026, Fractyl Health reported positive six-month randomized midpoint data from its REMAIN-1 study, showing Revita-treated patients had less weight regain and better cardiometabolic markers than sham after stopping GLP-1 drugs, and outlined plans to seek FDA De Novo classification. An interesting angle is that Revita is being explored specifically as a tool to help maintain weight loss after GLP-1 discontinuation, targeting a growing clinical gap. Against this backdrop, we’ll...

If you are wondering whether Alcoa's current share price still offers value after a strong run, this article will walk you through what the numbers are saying about the stock. The shares closed at US$56.81, with returns of 6.9% over the last 30 days, a 62.9% gain over the past year and 183.9% over five years, although the latest 7 day move was an 8.7% decline and year to date returns sit at 0.5%. Recent coverage of Alcoa has focused on how its share price reacts to shifts in sentiment around...

If you are wondering whether Cavco Industries at around US$492 per share still offers good value after a strong multi year run, this article will walk through what the current price could mean. The stock has seen a 26.3% decline over the last 7 days and a 16.8% decline year to date, while the 3 year and 5 year returns stand at 79.6% and 138.5% respectively. Recent coverage has highlighted Cavco Industries as a long term compounder in manufactured housing and as part of broader discussions on...

OceanFirst Financial (NasdaqGS:OCFC) reported its latest quarterly results with growth in commercial loans and deposits. Profitability was affected by higher expenses tied to outsourcing and merger related activity. The company also recorded net loan charge offs during the quarter. For you as an investor following regional banks, OceanFirst Financial sits in the middle of several important trends, including competition for deposits and a focus on commercial lending. The latest update around...

Financial Institutions (FISI) closed out FY 2025 with fourth quarter revenue of US$60.7 million and basic EPS of US$0.98, while trailing twelve month revenue came in at US$233.3 million and EPS at US$3.65. The company has seen quarterly revenue move from US$47.0 million in Q3 2024 to US$60.7 million in Q4 2025, with quarterly EPS shifting from a loss of US$5.07 in Q4 2024 to a profit of US$0.98 in Q4 2025. This sets the stage for investors to focus on how sustainable these margin and earnings...

Invesco Mortgage Capital (IVR) just posted its FY 2025 numbers with Q4 revenue of US$56.1 million and basic EPS of US$0.68, giving investors a fresh read on how the portfolio is trading through the mortgage market. Over recent periods, revenue has ranged from US$8.5 million in Q4 2024 to US$57.9 million in Q3 2025, while quarterly EPS has swung between a loss of US$0.40 in Q2 2025 and a gain of US$0.74 in Q3 2025, setting the backdrop for today’s print. With a trailing 12 month net margin of...

Moog (MOG.A) has opened Q1 2026 earnings season with a fresh set of numbers, coming off a recent quarter where revenue was US$1.0 billion and basic EPS came in at US$2.10, backed by trailing twelve month EPS of US$7.42 on revenue of US$3.9 billion. The company has seen revenue move from US$917.1 million in Q4 2024 to US$1.0 billion in Q4 2025, while quarterly basic EPS stepped up from US$1.39 to US$2.10 over the same stretch, setting the stage for investors to weigh how sustainable that...

Wintrust Financial (WTFC) has drawn fresh attention after reporting higher fourth quarter net interest income and net income year over year, along with a 10% increase to its quarterly common dividend and a separate preferred stock dividend declaration. See our latest analysis for Wintrust Financial. Those stronger fourth quarter earnings and higher dividends come after a steady run in the share price, with a 30 day share price return of 5.47% and a 90 day share price return of 13.42%, while...

First Reliance Bancshares (FSRL) has put up a busy FY 2025 so far, with Q3 revenue at US$12.1 million, basic EPS of US$0.34 and net income of US$2.7 million setting the tone for its latest update. The company has seen revenue move from US$10.2 million in Q2 2024 to US$13.8 million in Q2 2025, with EPS shifting from US$0.25 to US$0.46 over the same period. This gives you a clearer picture of how the income statement has evolved ahead of the current quarter. With net profit margins over the...

Central Pacific Financial (CPF) capped FY 2025 with fourth quarter total revenue of US$73.9 million and basic EPS of US$0.86, while trailing twelve month revenue came in at US$277.0 million and EPS at US$2.88. Over the last few quarters, the company has seen revenue move from US$57.6 million in Q4 FY 2024 to US$73.9 million in Q4 FY 2025, with quarterly EPS shifting from US$0.42 to US$0.86 over the same period. With trailing net margin now at 28.0% and profit growth flagged as strong in the...

Dover (DOV) closed out FY 2025 with fourth quarter revenue of US$2,099 million and basic EPS of US$2.02, alongside net income excluding extra items of US$274.8 million. The company has seen quarterly revenue move from US$1,930 million and EPS of US$1.74 in Q4 2024 to US$2,099 million and EPS of US$2.02 in Q4 2025, while trailing 12 month net profit margins have softened from 18.1% to 13.6%. This sets up a results season in which investors are likely to focus squarely on how sustainable those...

In January 2026, Precigen, Inc. reported that an independent expert consensus paper in The Laryngoscope recommended its FDA-approved HPV-specific immunotherapy PAPZIMEOS (zopapogene imadenovec) as the new first-line standard of care for adults with recurrent respiratory papillomatosis, shifting focus from repeated surgery to treating the underlying infection. Because the paper was sponsored by the Recurrent Respiratory Papillomatosis Foundation and shaped with input from patients and...

Wondering if UFP Industries is priced attractively at around US$103 per share, or if the easy money on this stock has already been made. The share price has been relatively active lately, with a 13.4% return over the last 30 days, a 12.0% return year to date, a 9.4% loss over the past year, and a 79.0% gain across five years. Recent coverage has focused on UFP Industries as a key player in the capital goods space, with investors watching how it positions itself across its core product lines...